95 related articles for article (PubMed ID: 11532516)
1. A minor E-selectin ligand, CD65, is critical for extravascular infiltration of acute myeloid leukemia cells.
Noguchi M; Sato N; Sugimori H; Mori K; Oshimi K
Leuk Res; 2001 Oct; 25(10):847-53. PubMed ID: 11532516
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia.
Di Noto R; Lo Pardo C; Schiavone EM; Ferrara F; Manzo C; Vacca C; Del Vecchio L
Leuk Lymphoma; 1996 Apr; 21(3-4):201-9. PubMed ID: 8726400
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis.
Terstappen LW; Safford M; Könemann S; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
Leukemia; 1992 Jan; 6(1):70-80. PubMed ID: 1540262
[TBL] [Abstract][Full Text] [Related]
4. Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia.
Di Noto R; Schiavone EM; Ferrara F; Manzo C; Lo Pardo C; Del Vecchio L
Leukemia; 1994 Nov; 8(11):1900-5. PubMed ID: 7967734
[TBL] [Abstract][Full Text] [Related]
5. Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis.
Brouwer RE; Hoefnagel J; Borger van Der Burg B; Jedema I; Zwinderman KH; Starrenburg IC; Kluin-Nelemans HC; Barge RM; Willemze R; Falkenburg JH
Br J Haematol; 2001 Nov; 115(2):298-308. PubMed ID: 11703324
[TBL] [Abstract][Full Text] [Related]
6. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
7. Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission.
Whiteway A; Corbett T; Anderson R; Macdonald I; Prentice HG
Br J Haematol; 2003 Feb; 120(3):442-51. PubMed ID: 12580958
[TBL] [Abstract][Full Text] [Related]
8. L and E selectins in acute myeloid leukemia: expression, clinical relevance and relation to patient outcome.
Aref S; Salama O; Al-Tonbary Y; Fouda M; Menessy A; El-Sherbiny M
Hematology; 2002 Apr; 7(2):83-7. PubMed ID: 12186696
[TBL] [Abstract][Full Text] [Related]
9. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Li L; Schmitt A; Reinhardt P; Greiner J; Ringhoffer M; Vaida B; Bommer M; Vollmer M; Wiesneth M; Döhner H; Schmitt M
Cancer Immun; 2003 Jul; 3():8. PubMed ID: 12862419
[TBL] [Abstract][Full Text] [Related]
11. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of adhesion molecules in acute leukemia.
Reuss-Borst MA; Klein G; Waller HD; Müller CA
Leukemia; 1995 May; 9(5):869-74. PubMed ID: 7539515
[TBL] [Abstract][Full Text] [Related]
13. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
[TBL] [Abstract][Full Text] [Related]
14. Expression and release of adhesion molecules by human acute myelogenous leukemia blasts.
Bruserud O; Ulvestad E
Leuk Res; 1999 Feb; 23(2):149-57. PubMed ID: 10071130
[TBL] [Abstract][Full Text] [Related]
15. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
Liu YR; Zhu HH; Ruan GR; Qin YZ; Shi HX; Lai YY; Chang Y; Wang YZ; Lu D; Hao L; Li JL; Li LD; Jiang B; Huang XJ
Leuk Res; 2013 Jul; 37(7):737-41. PubMed ID: 23601747
[TBL] [Abstract][Full Text] [Related]
16. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells.
Lin LI; Chen CY; Lin DT; Tsay W; Tang JL; Yeh YC; Shen HL; Su FH; Yao M; Huang SY; Tien HF
Clin Cancer Res; 2005 Feb; 11(4):1372-9. PubMed ID: 15746035
[TBL] [Abstract][Full Text] [Related]
17. All-trans retinoic acid promotes a differential regulation of adhesion molecules on acute myeloid leukaemia blast cells.
Di Noto R; Schiavone EM; Ferrara F; Manzo C; Lo Pardo C; Del Vecchio L
Br J Haematol; 1994 Oct; 88(2):247-55. PubMed ID: 7803267
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukaemia blast cells bind to human endothelium in vitro utilizing E-selectin and vascular cell adhesion molecule-1 (VCAM-1).
Cavenagh JD; Gordon-Smith EC; Gibson FM; Gordon MY
Br J Haematol; 1993 Oct; 85(2):285-91. PubMed ID: 7506565
[TBL] [Abstract][Full Text] [Related]
19. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R
Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
